Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.
Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedShow glossary and Hide glossary toggles were added to the page; there are minor label/capitalization changes (Last Update Submitted that Met QC Criteria vs met QC Criteria, No FEAR Act Data vs data) and the Revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check22 days agoChange DetectedThe page now displays a new site revision label: Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check44 days agoChange DetectedAdded a Locations section listing Texas as a site; removed the HHS Vulnerability Disclosure and the Texas Locations entry.SummaryDifference0.2%
- Check73 days agoChange DetectedThe publication status text updated to indicate auto-fill from PubMed and the revision version updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check80 days agoChange DetectedNotice about government funding and operating status was removed from the page. This does not affect the study details, eligibility criteria, or how to participate.SummaryDifference0.4%
- Check101 days agoChange DetectedNo significant changes to the study record are evident; the page content and major sections appear unchanged.SummaryDifference0.5%
Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.